AI Article Synopsis
- The study established age-specific reference intervals for anti-Müllerian hormone (AMH) in healthy Chinese boys aged 0-14 years.
- After birth, AMH levels increase slightly, drop sharply by age 2, and remain low after age 12, with significant negative correlations found between AMH and age, BMI, FSH, and testosterone levels.
- The research findings support the understanding of AMH's role in male growth and can inform clinical assessments related to testicular function and gonadal development.
Article Abstract
Background: Anti-Müllerian hormone (AMH) is used for evaluating gonadal development and testicular function. We aimed to establish AMH reference intervals and to determine the correlations between AMH level and age, body mass index (BMI), and follicle stimulating hormone (FSH), luteinizing hormone (LH), and total testosterone (TT) levels in healthy Chinese boys.
Methods: Serum AMH levels of 2,009 healthy boys (age, 0-14 years), recruited between October 2017 and April 2019, were determined using the Beckman Access 2 automated chemiluminescence immunoassay. Single-year-specific median, mean, and standard deviation (SD) of AMH and effects of age, BMI, FSH, LH, and TT on the AMH level were analyzed.
Results: The median and mean ± SD values of AMH increased slightly after birth. Serum AMH values decreased sharply at 2 years of age and were 6-7% of the birth level at 12 years, after which they remained low. Age-specific AMH reference intervals were established. Significant negative correlations were observed between AMH level and age (r = -0.75, P < 0.001); serum AMH levels were moderately negatively correlated with BMI (r = -0.35, P < 0.001), FSH (r = -0.37, P < 0.001), and TT (r = -0.45, P < 0.001) levels; and correlation with LH (r = -0.18, P < 0.001) was the weakest. In contrast, correlations between AMH and the LH/FSH ratio were not observed.
Conclusion: We established single-year-specific reference intervals for AMH in Chinese boys. Our findings revealed the changes in AMH secretion during normal male growth, and may provide a basis for the clinical use of AMH.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cca.2020.03.028 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Age and biologic survival in patients with moderate-to-severe psoriasis: A cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
Br J Dermatol
January 2025
Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, The University of Manchester, Manchester, UK.
Background: The current management of psoriasis does not differentiate between young and old patients in selecting the safest and/or most effective biologic.
Objectives: To explore the effect of age at treatment initiation in response to biologics in patients with moderate-to-severe psoriasis in the UK and Eire.
Methods: Data from patients registering to the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) from 2007-2024 on first course of Tumour Necrosis Factor (TNF), interleukin (IL) 12/13, IL-17 and IL-23 inhibitors (i) with at least 6 months' follow-up were included.
The application value of dynamic electroencephalography combined with brainstem auditory evoked potential in evaluating the degree of vascular stenosis and prognosis in patients with ischemic stroke: A retrospective analysis.
Medicine (Baltimore)
January 2025
Department of Neurology and Geriatrics, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, Chongqing, China.
The aim was to explore the application value of dynamic electroencephalography (EEG) combined with brainstem auditory evoked potential (BAEP) in evaluating the degree of vascular stenosis and prognosis in patients with ischemic stroke (IS). This was a retrospective study using clinical data of patients with IS admitted to the First Affiliated Hospital of Chongqing Medical and Pharmaceutical College from March 2020 to March 2022. The degree of vascular stenosis and prognosis of patients were analyzed.
View Article and Find Full Text PDFUsing the PROMOTE Screener to Identify Psychosocial Risk Factors for Prenatal Substance Use.
J Addict Med
November 2024
From the National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD (AA); Department of Obstetrics, Gynecology, and Reproductive Medicine, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY (ML, HP); and Department of Psychology, Stony Brook University, Stony Brook, NY (ML, CH, HP).
Introduction: There is an urgent need to improve the identification of psychosocial vulnerabilities in clinical practice (eg, stress, unstable living conditions) and examine their contribution to prenatal substance use, especially for legal substances such as alcohol, tobacco, and recently, cannabis.
Methods: We conducted a retrospective chart review of 1842 patients who completed the PROMOTE screening instrument during their first prenatal visit to outpatient clinics of a New York State health system in 6/2019-11/2020. The PROMOTE includes 18 core items to assess psychosocial vulnerabilities including the NIDA Quick Screen assessing past year substance use.
Low Vision Rehabilitation Referral Characteristics for Patients with Neovascular Age-Related Macular Degeneration.
Healthcare (Basel)
January 2025
Division of Ophthalmology, Department of Surgery, UMass Chan-Lahey School of Medicine, Burlington, MA 01805, USA.
: Despite evidence that low vision rehabilitation (LVR) services can improve visual function in patients with neovascular age-related macular degeneration (nAMD), many patients are not directed to access these resources. This study was conducted to determine factors associated with LVR referral and to assess the visual outcomes from completed evaluations. : The study comprised a retrospective, cross-sectional analysis of patients with nAMD.
View Article and Find Full Text PDFValidation of new items for diagnosing primary hyperhidrosis and the prevalence of primary hyperhidrosis.
Clin Exp Dermatol
January 2025
Department of Clinical Medicine, Copenhagen University, Denmark; Faculty of Health and Medical Sciences Department of Clinical Medicine Blegdamsvej 3b 33.5, DK-2200 Copenhagen, Denmark.
Background: The Multi-Specialty Working Group on the Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis developed evidence-based consensus criteria for diagnosing primary hyperhidrosis.
Objectives: To validate new questionnaire items for self-reported classification of primary hyperhidrosis based on the consensus criteria and to estimate the prevalence of primary hyperhidrosis.
Methods: This is a cross-sectional diagnostic accuracy study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!